Macquarie Group
CORT icon

Macquarie Group’s Corcept Therapeutics CORT Stock Holding History

Macquarie Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,706
Closed -$3.96M – 997
2025
Q3 		$3.96M Buy
47,706
+6,084
+15% +$440K ﹤0.01% 990
2025
Q2 		$3.05M Buy
+41,622
New +$3.02M ﹤0.01% 1100
2022
Q4 		– Sell
-1,146
Closed -$73K – 1834
2022
Q3 		$73K Sell
1,146
-1,716
-60% -$45.9K ﹤0.01% 1847
2022
Q2 		$68K Hold
2,862
– – ﹤0.01% 1971
2022
Q1 		$64K Hold
2,862
– – ﹤0.01% 2061
2021
Q4 		$57K Hold
2,862
– – ﹤0.01% 2118
2021
Q3 		$56K Hold
2,862
– – ﹤0.01% 2191
2021
Q2 		$63K Hold
2,862
– – ﹤0.01% 2111
2021
Q1 		$68K Sell
2,862
-814
-22% -$21.7K ﹤0.01% 2001
2020
Q4 		$96K Hold
3,676
– – ﹤0.01% 1884
2020
Q3 		$64K Hold
3,676
– – ﹤0.01% 1892
2020
Q2 		$62K Sell
3,676
-10,224
-74% -$144K ﹤0.01% 1877
2020
Q1 		$165K Hold
13,900
– – ﹤0.01% 1502
2019
Q4 		$168K Sell
13,900
-11,400
-45% -$159K ﹤0.01% 1659
2019
Q3 		$358K Hold
25,300
– – ﹤0.01% 1445
2019
Q2 		$282K Buy
+25,300
New +$282K ﹤0.01% 1493
2018
Q1 		– Sell
-17,300
Closed -$312K – 2202
2017
Q4 		$312K Buy
17,300
+10,200
+144% +$185K ﹤0.01% 1592
2017
Q3 		$137K Buy
+7,100
New +$106K ﹤0.01% 1848

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group's CORT Position: Q4 2025 in Review

Macquarie Group sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 47,706 shares — an estimated $3.96M sold.

Macquarie Group first reported a position in CORT in Q3 2017 and held it in 18 quarters. The position peaked at $3.96M in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Macquarie Group reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 47,706 Corcept Therapeutics shares in Q4 2025, an estimated $3.96M.
  • Macquarie Group first reported a position in Corcept Therapeutics in Q3 2017 and held it in 18 quarters.
  • Macquarie Group's Corcept Therapeutics position peaked at $3.96M in Q3 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.